Safety Shot Inc (SHOT)
USD 0.48
(-9.45%)
USD 0.48
(-9.45%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -12.18 Million USD | -6.06% |
| 2022 | -11.48 Million USD | 31.5% |
| 2021 | -16.77 Million USD | -226.6% |
| 2020 | -5.13 Million USD | -457.99% |
| 2019 | -920.28 Thousand USD | -156.77% |
| 2018 | -358.4 Thousand USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -8.41 Million USD | 45.23% |
| 2024 Q1 | -15.16 Million USD | -174.28% |
| 2023 Q1 | -1.24 Million USD | 81.92% |
| 2023 Q3 | -7.22 Million USD | -2275.08% |
| 2023 FY | -12.59 Million USD | -9.67% |
| 2023 Q4 | -5.53 Million USD | 23.41% |
| 2023 Q2 | -304.02 Thousand USD | 75.68% |
| 2022 FY | -11.48 Million USD | 31.5% |
| 2022 Q4 | -6.91 Million USD | -287.78% |
| 2022 Q3 | -1.78 Million USD | -99.78% |
| 2022 Q2 | -892.56 Thousand USD | 52.06% |
| 2022 Q1 | -1.86 Million USD | 71.97% |
| 2021 Q3 | -3.6 Million USD | 1.4% |
| 2021 Q4 | -6.64 Million USD | -84.17% |
| 2021 FY | -16.77 Million USD | -226.6% |
| 2021 Q1 | -2.86 Million USD | 22.72% |
| 2021 Q2 | -3.65 Million USD | -27.78% |
| 2020 Q4 | -3.7 Million USD | -551.46% |
| 2020 Q2 | -397.24 Thousand USD | 14.47% |
| 2020 Q1 | -464.42 Thousand USD | 28.62% |
| 2020 FY | -5.13 Million USD | -457.99% |
| 2020 Q3 | -568.68 Thousand USD | -43.16% |
| 2019 Q1 | -73.54 Thousand USD | 0.0% |
| 2019 Q4 | -650.68 Thousand USD | -412.22% |
| 2019 Q3 | -127.03 Thousand USD | -84.03% |
| 2019 FY | -920.28 Thousand USD | -156.77% |
| 2019 Q2 | -69.02 Thousand USD | 6.14% |
| 2018 FY | -358.4 Thousand USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Esperion Therapeutics, Inc. | -155.56 Million USD | 92.168% |
| Theratechnologies Inc. | -10.62 Million USD | -14.653% |
| Cosmos Health Inc. | -21.83 Million USD | 44.189% |
| Cronos Group Inc. | -81.37 Million USD | 85.027% |
| Ironwood Pharmaceuticals, Inc. | 209.03 Million USD | 105.829% |
| Kala Pharmaceuticals, Inc. | -39.15 Million USD | 68.881% |
| Organogenesis Holdings Inc. | 12.52 Million USD | 197.279% |
| Universe Pharmaceuticals INC | -3.52 Million USD | -245.476% |
| ProPhase Labs, Inc. | -21.61 Million USD | 43.626% |
| Sonoma Pharmaceuticals, Inc. | -4.7 Million USD | -159.182% |
| Dynavax Technologies Corporation | -37.02 Million USD | 67.095% |
| Radius Health, Inc. | -3.92 Million USD | -210.424% |
| China SXT Pharmaceuticals, Inc. | -2.51 Million USD | -384.417% |
| Alvotech | -354.86 Million USD | 96.566% |
| Sunshine Biopharma, Inc. | -4.78 Million USD | -154.616% |
| Alpha Teknova, Inc. | -35.56 Million USD | 65.739% |
| Intra-Cellular Therapies, Inc. | -159.38 Million USD | 92.355% |
| SCYNEXIS, Inc. | 72.66 Million USD | 116.767% |
| Harrow Health, Inc. | 580 Thousand USD | 2200.716% |
| Biofrontera Inc. | -22.67 Million USD | 46.271% |
| DURECT Corporation | -36.88 Million USD | 66.966% |
| Supernus Pharmaceuticals, Inc. | -5.26 Million USD | -131.242% |
| ANI Pharmaceuticals, Inc. | 46.97 Million USD | 125.94% |
| OptiNose, Inc. | -22.74 Million USD | 46.439% |
| RedHill Biopharma Ltd. | 12.63 Million USD | 196.455% |
| Aquestive Therapeutics, Inc. | -15.1 Million USD | 19.321% |
| Cumberland Pharmaceuticals Inc. | -6.21 Million USD | -96.176% |
| SIGA Technologies, Inc. | 83.62 Million USD | 114.571% |
| Lifecore Biomedical, Inc. | 9.33 Million USD | 230.577% |
| Shineco, Inc. | -17.06 Million USD | 28.605% |
| Phibro Animal Health Corporation | 53.31 Million USD | 122.853% |
| Procaps Group S.A. | 52.32 Million USD | 123.286% |
| TherapeuticsMD, Inc. | -8.52 Million USD | -42.956% |
| Regencell Bioscience Holdings Limited | -4.73 Million USD | -157.227% |
| Viatris Inc. | 766.2 Million USD | 101.59% |
| Sunshine Biopharma, Inc. | -4.78 Million USD | -154.616% |
| Rockwell Medical, Inc. | -6.67 Million USD | -82.671% |
| Incannex Healthcare Limited | -30.04 Million USD | 59.442% |
| Aytu BioPharma, Inc. | -5.25 Million USD | -131.902% |
| Tilray Brands, Inc. | -174.74 Million USD | 93.027% |
| Collegium Pharmaceutical, Inc. | 166.96 Million USD | 107.298% |
| PetIQ, Inc. | 60.01 Million USD | 120.302% |
| Silver Spike Investment Corp. | 7.34 Million USD | 265.994% |
| Neurocrine Biosciences, Inc. | 250.9 Million USD | 104.856% |
| Journey Medical Corporation | -2.07 Million USD | -487.755% |
| Alimera Sciences, Inc. | -1.47 Million USD | -728.29% |
| Petros Pharmaceuticals, Inc. | -13.61 Million USD | 10.525% |
| Assertio Holdings, Inc. | -243.53 Million USD | 94.997% |
| Shuttle Pharmaceuticals Holdings, Inc. | -5.89 Million USD | -106.778% |
| Embecta Corp. | 221.5 Million USD | 105.501% |
| Cyclo Therapeutics, Inc. | -20.05 Million USD | 39.231% |
| Procaps Group, S.A. | 38.97 Million USD | 131.263% |
| PainReform Ltd. | -9.58 Million USD | -27.13% |
| Avadel Pharmaceuticals plc | -137.84 Million USD | 91.161% |
| Hempacco Co., Inc. | -8.81 Million USD | -38.263% |
| Talphera, Inc. | -16.88 Million USD | 27.857% |
| Pacira BioSciences, Inc. | 87.67 Million USD | 113.897% |
| Alvotech | -354.86 Million USD | 96.566% |
| Lantheus Holdings, Inc. | 364.64 Million USD | 103.341% |
| Kamada Ltd. | 10.06 Million USD | 221.067% |
| Indivior PLC | -4 Million USD | -204.604% |
| Currenc Group, Inc. | -6.64 Million USD | -83.337% |
| Evoke Pharma, Inc. | -7.43 Million USD | -63.966% |
| Flora Growth Corp. | -50.35 Million USD | 75.803% |
| Cyclo Therapeutics, Inc. | -20.05 Million USD | 39.231% |
| Evolus, Inc. | -49.23 Million USD | 75.252% |
| HUTCHMED (China) Limited | 18.37 Million USD | 166.308% |
| Amphastar Pharmaceuticals, Inc. | 196.98 Million USD | 106.185% |
| Akanda Corp. | -10.05 Million USD | -21.219% |